Chemclin Diagnostics released its semi-annual performance, with a net profit attributable to the parent company of 24.34 million yuan, a year-on-year decrease of 68.24%

According to the Zhitong Finance APP, Chemclin Diagnostics disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 165 million yuan, a year-on-year decrease of 27.03%; net profit attributable to the parent company was 24.34 million yuan, a year-on-year decrease of 68.24%; net profit excluding non-recurring gains and losses was 15.92 million yuan, a year-on-year decrease of 77.35%; basic earnings per share were 0.06 yuan